These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35021982)

  • 21. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
    Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
    J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points.
    Al-Kuraishy HM; Al-Gareeb AI; Rauf A; Alhumaydhi FA; Kujawska M; El-Saber Batiha G
    CNS Neurol Disord Drug Targets; 2023; 22(6):875-883. PubMed ID: 35585806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.
    Ribeiro DE; Oliveira-Giacomelli Á; Glaser T; Arnaud-Sampaio VF; Andrejew R; Dieckmann L; Baranova J; Lameu C; Ratajczak MZ; Ulrich H
    Mol Psychiatry; 2021 Apr; 26(4):1044-1059. PubMed ID: 33328588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactoferrin for Mental Health: Neuro-Redox Regulation and Neuroprotective Effects across the Blood-Brain Barrier with Special Reference to Neuro-COVID-19.
    Naidu SAG; Wallace TC; Davies KJA; Naidu AS
    J Diet Suppl; 2023; 20(2):218-253. PubMed ID: 33977807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
    Amadoro G; Latina V; Stigliano E; Micera A
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.
    Amruta N; Chastain WH; Paz M; Solch RJ; Murray-Brown IC; Befeler JB; Gressett TE; Longo MT; Engler-Chiurazzi EB; Bix G
    Cytokine Growth Factor Rev; 2021 Apr; 58():1-15. PubMed ID: 33674185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic.
    Nawaz AD; Haider MZ; Akhtar S
    Biomol Biomed; 2024 Mar; 24(2):219-229. PubMed ID: 38078809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.
    Dziedzic A; Saluk-Bijak J; Miller E; Niemcewicz M; Bijak M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection.
    Pacheco-Herrero M; Soto-Rojas LO; Harrington CR; Flores-Martinez YM; Villegas-Rojas MM; León-Aguilar AM; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Corniel-Taveras CN; Dominguez-García JJ; Blanco-Alvarez VM; Luna-Muñoz J
    Front Neurol; 2021; 12():660087. PubMed ID: 33912129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Respiratory and Neurological Sequelae of COVID-19.
    Wang F; Kream RM; Stefano GB
    Med Sci Monit; 2020 Nov; 26():e928996. PubMed ID: 33177481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological manifestations and pathogenic mechanisms of COVID-19.
    Galea M; Agius M; Vassallo N
    Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialogue between Neuroinflammation and Neurodegenerative Diseases in COVID-19.
    Chowdhury B; Sharma A; Satarker S; Mudgal J; Nampoothiri M
    J Environ Pathol Toxicol Oncol; 2021; 40(3):37-49. PubMed ID: 34587403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?
    de Barros Viana M; Rosário BDA; de Fátima Santana de Nazaré M; Estadella D; Ribeiro DA; Socorro de Barros Viana G
    Rev Neurosci; 2021 Feb; 32(2):235-247. PubMed ID: 33185582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19.
    Tsagkaris C; Bilal M; Aktar I; Aboufandi Y; Tas A; Aborode AT; Suvvari TK; Ahmad S; Shkodina A; Phadke R; Emhamed MS; Baig AA; Alexiou A; Ashraf GM; Kamal MA
    Curr Alzheimer Res; 2022 Sep; ():. PubMed ID: 36089786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine "storm", cytokine "breeze", or both in COVID-19?
    Lippi G; Plebani M
    Clin Chem Lab Med; 2020 Dec; 59(4):637-639. PubMed ID: 33554554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.